The use of Matriderm and autologous skin grafting in the treatment of diabetic ulcers: a case report

Int Wound J. 2010 Aug;7(4):291-6. doi: 10.1111/j.1742-481X.2010.00687.x. Epub 2010 Jun 8.

Abstract

The aim of our case report was to analyse the results obtained with the Matriderm system and autologous skin grafting for the surgical treatment of diabetic ulcers. We recruited one patient with diabetic ulcers admitted at the Department of Plastic and Reconstructive Surgery, University of Rome 'Tor Vergata'. The patient underwent Matriderm system and autologous skin grafting for diabetic ulcer treatment. After just a single treatment, we obtained reduction in ulcer after 15 days from the surgical treatment. We achieved a reduction in pain and exudate secretion of the ulcer. We noticed an almost complete restoration of the missing volume and good quality of skin. Matriderm system and autologous skin grafting is a simple, safe and feasible technique. This method, when compared with other methods of treatment, is simple, cheap, less time consuming and does not require sophisticated laboratory facilities.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / drug therapy
  • Bacterial Infections / etiology
  • Collagen / therapeutic use*
  • Combined Modality Therapy
  • Diabetic Foot / complications
  • Diabetic Foot / pathology
  • Diabetic Foot / surgery*
  • Elastin / therapeutic use*
  • Exudates and Transudates
  • Humans
  • Male
  • Pain / etiology
  • Skin Care / methods
  • Skin Transplantation / methods*
  • Transplantation, Autologous / methods
  • Treatment Outcome
  • Wound Healing
  • Wound Infection / drug therapy
  • Wound Infection / etiology

Substances

  • Anti-Bacterial Agents
  • matriderm
  • Collagen
  • Elastin